Skip to main content

People in the News: Mar 3, 2009

Premium

Illumina CEO Jay Flatley has joined the board of directors of Helixis, a developer of nucleic acid analysis tools. Prior to joining Illumina, Flatley was president and CEO of Molecular Dynamics, now part of GE Healthcare, and led that company's initial public offering in 1993.


Mari Baker this week will leave her job as CEO and president of Navigenics, where she served since the company started in 2007. Baker has taken on the job of CEO of an entertainment and video game company called Playfirst.

While the company searches for a replacement, board members Dana Mead and Sue Siegel will manage the business. Baker will continue to serve as a board member.


Warren Kocmond has been named CEO of Electroglas, the firm said last month. He previously held the position of chief operating officer since May 2008.

Before that, Kocmond was senior vice president of global operations for Affymetrix. He also served as CEO of Earth Renewable Energy and COO at Asyst Technologies.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.